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Abstract: In the last two decades, large scale axenic cell cultures of the marine species 
comprising the family Euplotidae have resulted in the isolation of several new classes of 
terpenoids with unprecedented carbon skeletons including the (i) euplotins, highly strained 
acetylated sesquiterpene hemiacetals; (ii) raikovenals, built on the bicyclo[3.2.0]heptane 
ring system; (iii) rarisetenolides and focardins containing an octahydroazulene moiety; and 
(iv) vannusals, with a unique C30 backbone. Their complex structures have been elucidated 
through a combination of nuclear magnetic resonance spectroscopy, mass spectrometry, 
molecular mechanics and quantum chemical calculations. Despite the limited number of 
biosynthetic experiments having been performed, the large diversity of ciliate terpenoids 
has  facilitated  the  proposal  of  biosynthetic  pathways  whereby  they  are  produced  from 
classical  linear  precursors.  Herein,  the  similarities  and  differences  emerging  from  the 
comparison  of the classical  chemotaxonomy approach  based on secondary metabolites, 
with species phylogenesis based on genetic descriptors (SSU-rDNA), will be discussed. 
Results  on  the  interesting  ecological  and  biological  properties  of  ciliate  terpenoids  are  
also reported.  
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1. Introduction  
Ciliate is the common name assigned to a protist taxon comprising the phylum Ciliophora. Over 
7000 ciliate species have been described from marine, freshwater and terrestrial habitats, where they 
play  a  key  role  in  microbial  food  webs.  These  eukaryotic  microorganisms  are  characterized  by  a 
nuclear dualism and body-covering cilia used for locomotion and feeding. Relying solely on their 
outwardly  visible  characteristics  as  the  main  discriminating  parameters  for  identifying  protistan 
species, some claim that protists show a poor biodiversity [1,2] and thereby wrongly assume that this is 
accompanied  by  poor  chemical  diversity  [3].  However,  there  is  increasing  evidence  that  protists 
express a biodiversity comparable to other taxa [4,5]. Furthermore, the genetic distance among ciliate 
taxa of the same taxonomic rank, species included, is far larger than that occurring among  many 
multicellular  representatives.  The  fact  that  protists  violate  the  first  species  property  (i.e., 
morphological  uniqueness)  does  not  imply  that  other  species-specific  properties  cannot  undergo 
selective pressures leading to new, separate evolutionary units. The low level of biodiversity found in 
protists to-date is likely to be a reflection of the lack of workable methods for addressing the species 
problem in protists. Hence, it may frequently occur that two strains showing the same identifying, 
morphological features behave quite differently. Molecular genetic methodologies have provided a 
powerful means to address the protistan systematic-taxonomic problems. The outcomes of these new 
approaches  strongly  suggest  that  establishment  of  protistan  biodiversity  is  a  task  that  has  just 
commenced  [6].  Moreover,  in  the  last  two  decades  detailed  investigation  of  ciliate  secondary 
metabolites from the genus Euplotes has added “a new dimension” to the problem of their species-
specific allocation via a "chemotaxonomic" approach, which is able to define protistan taxonomy to 
the subspecific level [7]. In line with current views of protistan microbiologists, the results obtained by 
the  latter  approach  have  highlighted  a  rich  diversity  of  ciliate  secondary  metabolites.  Further 
investigation into the morphological, physiological, and ecological properties of this interesting taxon 
is therefore essential, especially given the interest in their exploitation as new biotechnological tools. 
From a natural products point of view, ciliates are microorganisms able to synthesize, inter alia, 
secondary metabolites belonging to three main biogenetic classes. The first class is represented by 
pheromone peptides and proteins, of which structural, functional, and evolutionary properties have 
been described by Luporini and co-workers. These cell-specific signal proteins, isolated from ciliated 
protozoa belonging to the genus Euplotes, constitutively diffuse into the extracellular environment [8]. 
Among the several peptide pheromones isolated from marine ciliates, the shortest show sequences of 
38–40  amino  acids  arranged  to  form  a  bundle  of  three  -helices,  which  have  an  up-down-up 
orientation  and  are  maintained  in  close  juxtaposition  by  three  to  four  disulfide  bonds  located  in 
conserved positions within the family. From a functional point of view, these peptides have been 
demonstrated  to  induce  mating  of  cells  via  paracrine-like  (or  heterotypic)  interactions  and,  as  a 
consequence of their autocrine binding, to promote the vegetative (mitotic) proliferation of the same Mar. Drugs 2010, 8                       
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cells from which they are released. The second class of products reported from ciliates is broadly 
defined as ciliate pigments, which are compounds of mixed biosynthetic origin. In particular, ciliates 
are known to produce three main families of pigments (Scheme 1). The first contains metabolites built 
on the hypericin skeleton such as stentorin  (1) [9] and blepharismin C (2)  [10,11]; the second is 
represented  by  compounds  wherein  a  ß -bromine  substituted  pyrrole  is  linked  to  a  sulfate  pyrone 
through an extended conjugated chain, such as keronopsin (3) [12]; and the last derives from a peptide-
like  linked  brominated  tyramine  with  a  brominated  pyrrole  carboxylic  acid,  such  as  the 
keronopsamides A (4) [13]. Although the bioactive alkyl-resorcinols isolated from Climacostomum 
virens [14], the so called “climacostol family”, are not true pigments, they can broadly be thought to 
belong to this class, being metabolites of mixed biosynthetic origin. 
Scheme 1. Pigments isolated from freshwater and marine ciliates. 
 
From the early 90s, investigation into the natural products from marine ciliates belonging to the 
genus Euplotes revealed a dominance in the production of terpenoids. At that time, only one study on 
crude  extracts  of  Tetrahymena  pyriformis  reported  the  production  of  the  polycyclic  triterpene 
tetrahymanol, an important metabolite along the squalene cyclization cascade [15]. In 1992, the ability 
to obtain large mass cultures of the marine morphospecies Euplotes crassus led to the isolation of the 
highly strained acetylated hemiacetals, the first sesquiterpenoids from marine protists. Since then, the 
intra- and interspecific diversity of ciliates has been widely investigated. 
This review summarizes the results of almost two decades of research in the field by the authors, 
but also, and more importantly, presents a unifying picture of the chemical and biological results, 
including both reported and previously unpublished data. The review begins with a short description of 
the approach used to tackle the topic. As shown schematically in Figure 1, a general methodology that 
relies  on  strong  collaboration  between  microbiologists,  molecular  biologists  and  natural  product 
chemists is essential. For each investigated morphospecies the following is discussed: (a) the chemical 
structures and reactivity of the isolated terpenoids; (b) the intra-species chemical diversity; (c) putative Mar. Drugs 2010, 8                       
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biosynthetic pathways accounting for the formation of the isolated terpenoids; (d) the intra-species 
biological diversity through phylogenetic relationships; and (e) the results of bioactivity screening. 
The  evolutionary  significance  of  these  metabolites  is  described  in  the  last  section,  along  with  a 
comparison of the outcomes from the analysis of micromolecular markers (terpenoids) with that of 
macromolecular descriptors (SSU-rRNA). 
Figure  1.  The biological (blue boxes) and chemical (red boxes) steps of an integrated 
approach, leading to an understanding of the functional roles of secondary metabolites 
from marine ciliates (green boxes). 
 
2. Generalities on Biological and Chemical Methodologies  
2.1. Cell cultures, ecological tests and phylogenetic analysis 
All the Euplotes strains collected were established starting from single naturally occurring cells to 
obtain cellular line clones, which were fed on both microalgae and bacteria. Mass cultures were grown 
in salt water (32‰ salinity), sterilized, and inoculated with microalgae, with the latter first incubated at 
23 ±  1 ° C in a 12 h light/dark cycle for at least 10 days using a daylight (Osram Daylight lamp,  
36 W/10) and fluorescent (Osram Fluora lamp, 40 W/77) illuminated incubator system. Ciliates thrive 
in  a  continuously  percolating  culture  of  the  autonomously  reproducing  autotrophic  microalgae, 
representing a renewable source. 
Starved cells from mass cultures of the strains were pelletted by successive centrifugation rounds to 
provide from 0.01–0.1 mL of closely packed ciliates for small-scale cell cultures to 0.1–20 mL for 
large-scale  samples.  Small-scale  cell  cultures  were  used  for  the  morphological  and  phylogenetic Mar. Drugs 2010, 8                       
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analyses.  Morphological  information  was  obtained  from  living  and  fixed  specimens,  employing 
differential  interference  contrast microscopy  (DIC)  and scanning electron microscopy (SEM). The 
silver nitrate impregnation protocol devised by Foissner et al. [16] and the standard Feulgen staining 
procedure were applied after cell fixation in Bouin’s fluid to reveal the nuclear apparatus. In assigning 
strains to the appropriate morphospecies, the intra- (within and between strains) and inter-population 
variability was considered. Eleven characters commonly used for morphological distinctness among 
Euplotes taxa were chosen. The determination of the phenotypic traits was carried out on 10 selected 
specimens  of  each  preparation  at  1000X  magnification  on  a  Leica  DMR  microscope,  using  the 
dedicated Leica IM1000 version 1.0 software STATISTICA (StatSoft, Inc., USA). Data produced by 
this  morphometric  procedure  were  analyzed  using  the  multivariate  technique  of  discriminating 
functions. 
To gain insight into the taxonomic and phylogenetic relationships among con-generic species of 
Euplotes,  the  nuclear  small  subunit  rRNA  (SSU-rRNA)  gene  was  selected  to  determine  the 
phylogenetic  trees.  The  nuclear  SSU-rRNA  gene  sequences  were  amplified  by  polymerase  chain 
reaction (PCR) of DNA prepared from small-scale cell cultures concentrated by centrifugation and 
incubated in lysis buffer (0.5 M EDTA, 1% SDS, 10 mM Tris-HCl, pH 9.5) containing proteinase K 
(200  g/mL),  at  55  ° C  for  12–15  h.  The  universal  eukaryotic  forward  primer  18S  F9  
(5’-CTGGTTGATCCTGCCAG-3’)  [17]  and  the  18S  R1513  Hypo  reverse  primer  
(5’-TGATCCTTCYGCAGGTTC-3’) were used [18]. The PCR products were directly sequenced in 
both  directions  with  one  forward  [F783  (5’-GACGAAATCAAAGAAATACCGTC-3’)]  and  two 
reverse [R536 (5’-CTGGAATTACCGCCGGCTG-3’) and R1052 (5’-AACCTTAAGGAACCCCCG 
GCCATGGCAA-3’)] internal primers [18]. The SSU-rRNA gene sequences were aligned using the 
program ClustalX [19] with default parameter settings. The alignment was adjusted interactively with 
the  program  BioEdit  Sequence  Alignment Editor  [20] to  optimize  the base-pairing scheme  of the 
rRNA gene molecule secondary structure [21]. The phylogenetic analysis was performed in PAUP 
version 4.0b10 [22], applying a neighbor joining method and using Modeltest 3.06 [23] to select the 
appropriate model of substitution. The Akaike Information Criterion (AIC) indicated that the Tamura-
Nei model [24], which considers unequal base frequencies, was the most appropriate. The reliability of 
the internal branches of the phylogenetic tree was assessed using the bootstrap method [25].  
Biological/ecological  tests  were  carried  out  on  various  strains  of  the  different  morphospecies. 
Responses of strains to metabolite treatments were assessed by examining the impact on cell fission 
rates and cell tolerance. Cleaving cells were isolated from well-fed cultures, thus producing groups of 
physiologically  synchronized  single  progeny  individuals.  These  fission  progeny  cells  normally 
underwent at least one fission in ciliates of larger size, or two fissions in ciliates of smaller size. Using 
a micropipette, they were individually transferred to wells of three-spot hemispheric depression slides 
for  16  h  incubation  in  salt  water,  sterilized,  and  then  assessed  in  the  absence  (control)  or  in  the 
presence of metabolite. The cultures were kept under observation by light microscopy. The effects of 
each experimental treatment, as well as the controls, were scored on a series of nine cells, individually 
distributed into the depressions. The fission rate of a cell’s progeny was calculated using the formula: 
n  =  log2  nx;  where  n  is  the  fission  number  performed  by  a  single  cell  since  its  isolation  into  a 
depression, and nx is the number of cells scored after 16 h. Cells that were unable to swim or creep on 
the bottom of the depression, or with motionless cirri (or both), were considered dead.  Mar. Drugs 2010, 8                       
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All the terpenoids reported here, including those isolated from E. focardii, have been tested using 
an unbiased sample of marine interstitial ciliates in order to verify their biological activities. 
2.2. Cell extracts, de-replication analysis, isolation and structure elucidation of secondary metabolites 
Since secondary metabolites in ciliates are not-dispersed in the culture-medium, cells obtained by 
centrifugation were extracted in ethanol and stored in the same solvent (at -20 ° C) prior to analysis. 
Rapid identification and quantitative estimates of known compounds were obtained from the ethanol 
extracts using de-replication techniques based on liquid chromatography-tandem mass spectrometry 
(LC-MS/MS) methods. Photo diode array was used for UV-Vis detection, while sample MS ionization 
used an ESI or APCI ion-source (in either positive- or negative-ion mode) coupled to an ion trap mass 
analyzer.  An  aliquot  of  5  μL  of  the  ethanol  solution  of  each  sample  (the  supernatant  of  the  cell 
suspension containing about 0.2 mL of cell-pellet in 1 mL of alcohol) was injected into a C18 column 
(4.6  ×   150  mm,  3.5  m)  with  a  7:3  mixture  of  CH3CN/H2O  as  the  eluent  and  a  flow  rate  of  
0.9 mL/min. 
In order to isolate pure metabolites, the ethanol solution obtained through cell pellet filtration was 
evaporated  and  the  residue  partitioned  between  hexane-ethyl  acetate  9:1  (organic  part)  and  
methanol-water 9:1 (aqueous part). The organic extract was then subjected to reversed-phase flash 
chromatography  (RP-FC)  on  a  Lichrolut  RP18  column  with  a  CH3CN-MeOH  gradient  elution, 
collecting 5 fractions of about 2 mL. The first fractions that eluted usually contained the terpenoid 
metabolites, which could be further purified by RP semi-preparative HPLC (RP18, CH3CN-H2O 7:3,  
5  mL/min).  The  latter  FC  fractions  contained  different  classes  of  lipids  such  as  sterols,  di-  and 
triacylglycerols, free fatty acids and phospholipids. Structural elucidation of the compounds under 
investigation  was  performed  using  nuclear  magnetic  resonance  (NMR)  spectroscopy,  mass 
spectrometry  (MS)  and  infrared  spectroscopy  (IR),  combined  with  the  results  from  molecular 
mechanics (MMX and MM3 force fields) and density functional theory (DFT).  
3. Terpenoids from Euplotes crassus  
3.1. Structures, chemical reactivity and total synthesis  
When  investigation  into  marine  ciliated  protozoa  in  the  subclass  Hypotrichida  first  began, 
morphological data proved ambiguous in deciding whether Euplotes vannus and Euplotes crassus were 
separate species or part of a species complex. Indeed, the Euplotes vannus-crassus-minuta group is a 
complex of closely related, cosmopolitan, marine ciliates, for which the ability to distinguish between 
them continues to be contentious. Three morphospecies have been identified with E. vannus being the 
largest  form,  E.  minuta  the  smallest,  and  E.  crassus  presenting  intermediate  morphological 
characteristics.  In  particular,  the  morpho-variability  of  E.  vannus  and  E.  crassus  is  low  and  their 
microscopic identifying features are not clearly separated (Figure 2, left). 
Starting  with  the  most  frequently sampled hypotrichid  E. crassus, strains  collected  in  different 
geographical sites have all been found to give the same secondary metabolites, referred to as the 
euplotins  (Scheme  2). These are  sometimes  also  accompanied by their putative  acyclic precursor, 
preuplotin [26]. Thin-layer chromatography (TLC) can be used to distinguish the protozoan E. crassus Mar. Drugs 2010, 8                       
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as it is the only euplotin producer within the E. vannus-crassus-minuta complex of sibling species. As 
shown  in  Figure  2,  for  E.  crassus  extracts,  three  UV  active  spots  ascribed  to  euplotin  A,  B  and 
preuplotin  are  detected,  along  with  a  dark  spot  (Retention  factor,  Rf  0.62)  for  euplotin  C,  which 
appears  upon  staining.  For  E.  minuta,  only  preuplotin  is  detected,  while  strains  of  the  E.  vannus 
morphospecies contain neither euplotin nor preuplotin.  
Figure  2.  Left:  Transmission  electron  microscopy  (TEM)  image  of  Euplotes  crassus, 
Euplotes minuta and Euplotes vannus ciliates; Right: TLC plate (stationary phase: Merck 
Si60 PF254, eluent: n-hexane-ethyl ether 1:1, staining reagent: Ce(SO4)2/H2SO4) of crude 
cell  extracts  (0.1  mL  of  cell  pellet)  from  typical  strains  of  E.  crassus,  E.  minuta  and  
E. vannus. 
E. crassus
E.minuta
E. vannus
    
A  typical  chromatogram  obtained  from  analysis  of  an  E.  crassus  strain  (Pdr1)  is  reported  in  
Figure 3, showing the chromatographic separation of the euplotins, characterized by peak-selective 
UV and ESI-MS ion spectra. Depending on the environment of the electrospray ionization chamber, 
concentration and composition of the eluate, the sodium adduct [M + Na]
+ of the molecular ion is 
usually detected in the positive-ion mode ESI-MS spectrum, followed by potassium adducts [M + K]
+ 
and/or dimeric ion-species [2M + 2Na]
2+. This analysis provides both qualitative and quantitative data 
and  is  currently  employed  in  the  initial  de-replication  analysis  of  new  strains.  With  a  single  
HPLC-UV-MS  run,  three  important  pieces  of  molecular  information  are  obtained  simultaneously: 
polarity  (retention  time,  tR),  chromophoric  groups  (UV-Vis  spectra),  and  molecular  weight  (MS 
spectra) of every metabolite eluted by the LC system. These data can also be used to track metabolic 
changes during the life-cycles of the microorganisms.  Mar. Drugs 2010, 8                       
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Figure 3. LC-UV chromatogram ( 220 nm) of a crude extract of Euplotes crassus (strain 
Pdr1): for all metabolites UV spectra are reported on the top and ESI(+)-MS spectra at  
the bottom.  
 
In all investigations on different strains of E. crassus, the acetylated sesquiterpenoid euplotin C (7) 
was  the  most  abundant  metabolite,  and  can  thus  be  used  as  a  chemotaxonomic  marker  of  this 
morphospecies. Euplotin C is often followed by at least one of its structural analogs, euplotin A (5) or 
euplotin B (6), and occasionally by the putative acyclic precursor, preuplotin (8) (Scheme 2) [27]. 
The euplotane skeleton is a tricyclic ring system, built on a trialdehyde-masked system wherein an 
unusual 2,6-trans-stereochemistry imposes a high degree of strain on the overall structure. According 
to ab initio DFT calculations, the 2,6-trans ring junction leads to an increase in the euplotin strain 
energy of about 12 kcal/mol compared to that of the diastereoisomeric 2,6-cis analog (Scheme 2, 
bottom). Interestingly, the structural features of the latter are present in udoteatrial hydrate [28], a 
diterpenoid isolated from the marine alga Udotea flabellum.  
Another feature of the euplotins is their high chemical instability [16]. In mild basic conditions, 
euplotin C readily undergoes a cascade of irreversible transformations, leading to four major products, 
as regio- and diastereoisomeric mixtures (9–12 in Scheme 3). Loss of the acetate group at C(15), 
releases the strain imposed by the trans 2–6 ring junction in the euplotane skeleton, since the incipient 
C(14)  aldehyde  in  the  hypothetical  trialdehyde  intermediate  is  far  from  the  C(1)  aldehyde  group, 
regardless of the relative stereochemistry. Curiously, while C(1) and C(15) are strongly involved in 
mutual acetal condensations induced by nucleophilic attack of MeOH, the C(14) aldehyde group does 
not cause any acetalization. The analysis of the end-products of this reaction confirmed the euplotins 
structure, and also allowed the establishment of their absolute configuration through the application of 
the modified Mosher method [30,31] involving MTPA esterification of the hemiacetal groups of the 
regioisomers 9 and 10 [16].  Mar. Drugs 2010, 8                       
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Scheme  2.  Top:  Sesquiterpenoids  5–8  isolated  from  cell  cultures  of  Euplotes  crassus. 
Bottom:  Molecular  mechanics  minimized  structures  of  euplotin  C  (left,  trans  2–6  ring 
junction) and of its hypothetical more stable C(6) epimer (right, cis 2–6 ring junction).  
 
Different results were obtained when euplotin C (7) was subjected to mildly acidic conditions (e.g., 
p-toluensulfonic  acid  in  methanol).  NMR  analysis  of  the  reaction  products  indicated  complete 
acetalization at C(1) and C(15) (no hemiacetals present) and, more importantly, that the incipient 
C(14) aldehyde group was trapped by the sp
2 C(12) in a carbonyl-ene type reaction, affording the 
expected hydroxy-cyclopentane ring [as an epimeric mixture at C(14)] as in the derivatives 13 and 14. 
The  latter  derivative,  14,  is  derived  from  acid-catalyzed  electrophilic  attack  of  MeOH  on  the  
iso-propylidene moiety of 13. As it will become clearer further on, the possibility of acid-catalyzed 
carbonyl-ene processes is of paramount importance since this kind of intramolecular cyclization seems 
to play a dominant role in the biosynthesis of the majority of terpenoids isolated from marine ciliates.  
Scheme 3. Hydrolysis of euplotin C (7) under either mildly basic or acidic conditions. 
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Euplotins are also amphiphilic molecules, with a “water-like” polar part defined by an unusual 
sequence of electron-withdrawing oxygen atoms, as well as a hydrophobic tail. It is therefore not 
surprising that they give rise to micellar aggregates in water, at least above their critical concentration 
(CMC). Although the CMC value of euplotins in aqueous solution or the size of their aggregates has 
not been measured, evidence of micellar phases can be obtained from line-width analysis of 
1H-NMR 
spectra taken on aqueous samples containing euplotins at different concentrations. In particular, NMR 
experiments carried out on euplotin C (7) supported the formation of large molecular aggregates by the 
appearance of strong signal broadening in aqueous 
1H-NMR spectra due to significant decreasing of 
their  transversal  relaxation  times  T2.  These  aggregates  are  only  partially  destroyed  by  extensive 
sonication treatment, as evidenced by NMR spectra signal re-sharpening. 
Euplotins A–C (5–7) are even unstable in water, but the end-products are different from those 
discussed above in methanol solutions. In general terms, the increase of the reactant concentration in 
the micellar phase is expected to lead to a considerable acceleration of the hydrolysis reaction due to 
the  well  known  micellar  catalysis  effect  [31].  With  euplotins  as  reactants,  however,  it  could  be 
demonstrated  through  LC-UV-MS  techniques  and  deuterium  incorporation  experiments  that  three 
consecutive  chemical  processes  occur.  First,  there  is  an  initial  fast  process  leading  to  hydrolytic 
cleavage of the C(15) acetate. Second, there is an electrophilic addition of water to the activated 
C(7)=C(14) vinyl ether double bond. Third, there is an electrophilic addition of water, catalyzed by 
acetic acid (deriving from process 1), to the C(10)=C(11) trisubstituted double bond of the prenyl side-
chain. While the first two reactions proceed with similar rate constants, the last is much slower and 
becomes significant only after complete disappearance of the starting reactant, euplotin C (7). Free 
aldehydes are expected to be labile intermediates playing an equilibration role among the hemiacetal 
intermediates, but in these experiments they were undetectable.  
Only  one  report  has  so  far  been  published  on  the  total  synthesis  of  euplotins.  Euplotin  A  
(5, Scheme 2) has been synthesized [33] by exploiting the thermal reactivity of suitable heterodienes 
(2-acylalkenals) that undergo cycloaddition reactions giving the key 5-acyldihydropyran intermediate 
with  the  correct  euplotane  trans  2–6  stereochemistry.  Racemic  euplotin  A  has  been  obtained  by 
functional group transformations.  
3.2. Inclusion complexes 
Since euplotins are rather hydrophobic compounds, their low water solubility represents a serious 
limitation to the reliability of any bioassay method. In order to overcome these difficulties, inclusion 
complexes  of  euplotin  C  with  cyclodextrins  (CD)  were  prepared  [34].  After  various  trials  with 
different  CD  derivatives,  heptakis(2,6-di-O-methyl)-β-cyclodextrin  (DIMEB)  was  finally  chosen 
because of its binding capability and enhanced water solubility. The complex stoichiometry, binding 
constants and three dimensional structure of the 1:1 inclusion complex of euplotin C(7)-DIMEB were 
determined using 1D/2D-NMR techniques and LC-ESI tandem MS measurements. The data suggests 
that, in aqueous solution, 7-DIMEB has a 1:1 stoichiometry, although a 1:2 ratio cannot be ruled out at 
least  at  high  DIMEB/7  molar  ratio.  By  using  LC(PDA)-MS/MS  as  the  probe  technique,  kinetic 
investigations of the hydrolysis of the 7-DIMEB complex demonstrated that complexed-7 gives rise to 
the same end-products as free-7 alone, although every step of the overall hydrolytic process occurs at a Mar. Drugs 2010, 8                       
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lower rate. Thus, the increased solubility and the lower hydrolysis rate of complexed-7 with respect to 
free-7, suggested that these inclusion complexes can be used in biological tests as reliable sources of 
euplotin C (7), avoiding the use of organic solvents such as DMSO as the carrier agent.  
3.3. Biogenetic considerations 
A putative biosynthetic route to the euplotins from farnesyl pyrophosphate (FPP) via preuplotin (8) 
as a key intermediate is shown in Scheme 4. After C1 pyrophosphate hydrolysis, it is proposed that 
intermediate 15 could undergo C6=C7 double bond isomerization, along with acetylation of the OH 
groups at C(1) and C(15), to give the 1,4-dienol acetate moiety of preuplotin (8). Hydrolysis of 8 
followed by nucleophilic addition of the electron rich C(2) to the electron poor C(6) would then afford 
the trialdehyde terpenoid 16. Thereafter nucleophilic attack by water at C(14), followed by a cascade 
of  internal  acetalizations,  would  lead  to  euplotin  C  (7)  via  ß -elimination  of  water  and  O-C(15) 
acetylation  of  the  hemiacetal  diastereoisomeric  mixture  17. Biosynthetic experiments  with  labeled 
isotopic  precursors  are  planned  by  the  authors  of  this  review,  in  order  to  support  the  proposed 
biosynthetic route described above and to establish whether or not terpenoid biosynthesis in marine 
ciliates follows the classical mevalonate pathway [35]. It should be noted, however, that no biogenetic 
data on the euplotins is currently available. 
Scheme 4. Biogenetic proposal of Euplotes crassus sesquiterpenoids. 
 
Three main aspects of the biosynthetic proposal must be highlighted because they are atypical of 
classical terpenoid biosynthesis. The first is that intramolecular cyclizations are not usually driven by 
nucleophilic  additions  but  by  carbocation-mediated,  electrophilic  reactions  [36,37].  In  fact,  these 
cyclizations are typically initiated by a regiochemical addition of an electrophile to a sp
2 hybridized 
carbon generating a carbocation, which in turn undergoes subsequent ring forming reactions. In marine 
organisms  this  process  is  often  initiated  by  bromine  induced  electrophilic  attack  of  double  bonds 
leading to a plethora of haloterpenoids [38]. The second point is that in terpenoid biosynthesis, C(1) 
usually plays a pivotal role as the electrophilic site of the first intermediate after allylic diphosphate 
hydrolysis, whilst the C(14) and C(15) methyl groups are rarely used in ring forming processes. The 
opposite is proposed to occur in the E. crassus metabolism, where the key biogenetic step would be the 
stereoselective C(2)–C(6) bond formation, possibly deriving from conjugate addition of electron rich 
C(2) to the electrophilic site at C(6). In fact, the oxidation of C(14) to -CHO inverts the polarity of the Mar. Drugs 2010, 8                       
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C(6)=C(7) double bond making the -carbon at C(6) particularly electron-poor. At the same time, the 
hydrolysis/oxidation of C(1) to -CHO makes the -carbon C(2) an electron-rich, nucleophilic site. 
Finally,  in  classical  terpenoid  biogenesis,  oxidations  are  usually  thought  of  as  final  processes 
(sometimes even occurring as  isolation artefacts), whereby the end-products (or late carbocationic 
intermediates) are ultimately quenched by the capture of an external nucleophile such as water.  
Enzymes  such  as  terpene  cyclases  that  would  be  responsible  for  converting  the  sesquiterpene 
precursor FPP into species-specific secondary metabolites in ciliates are expected to be structurally 
and functionally different from classical cyclases involved in terpenoid biosynthesis of other phyla. 
This is because they are expected to recognize oxidized FPPs as substrates. Marine ciliates could, 
however, share the enzymatic pool leading from mevalonic acid (MVA), or from 1-deoxyxylulose-5-
phosphate (DXP) [37] to isopentenyl diphosphate (IPP) and FPP.  
3.4. Intra-morphospecies phylogenetic analysis  
Euplotes crassus is a cosmopolitan and highly diffused marine morphospecies, with an ability to 
cope with changing environmental conditions [4,39,40]. This may play an important role in ecological 
significance of this morphospecies, while the production of the euplotins could be another element in 
their survival strategy [27]. The branching of the phylogenetic tree denotes, within the morphospecies 
analyzed, the presence of four distinct groups, all including representatives of cosmopolitan origin 
(Figure 4). Inter-population variation in genetic determinants following geographical separation would 
be expected to occur, and would result in the production of distinct secondary metabolites.  
Figure 4. Schematic representation of the phylogenetic tree, based on SSU-rRNA gene 
sequence comparisons, of different strains of Euplotes crassus. The numbers at the nodes 
are bootstrap percentages from 1000 replicates. The scale bars correspond to a distance of 
2 substitutions per 1000 nucleotide positions. 
 
Although  most  strains  of  E.  crassus  produce  the  same  secondary  metabolites,  there  are  some 
exceptions. For example, several strains do not produce preuplotin (8), while other strains do not 
produce euplotin A (5). Some strains produce euplotin C (7) only in very low quantities accompanied Mar. Drugs 2010, 8                       
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by trace amounts of preuplotin (8). Furthermore, the population SL represents an exception within  
E. crassus being the only strain which does not produce any euplotins at all. From an evolutionary 
point  of  view,  euplotins  are  the  result  of  a  metabolic  pathway,  which  appears  useful  in  natural 
selection,  regardless  of  the  environmental  conditions.  This  may  explain  its  ubiquity  and  larger 
distribution  with  respect  to  other  morphospecies  that  share  the  same  habitats,  like  E.  vannus  and  
E. minuta. 
3.5. Ecological role and biological activities 
At the onset of the investigations, there were two hypotheses regarding the way in which E. crassus 
exchanges chemical information: (i) by the release of substances into the extracellular medium, or (ii) 
by  direct  cell-to-cell  contacts.  Reported  studies,  carried  out  in  vivo,  suggested  that  euplotins  are 
utilized to inhibit populations of competitors via cell-to-cell contact, a good strategy to colonize new 
habitats or defend settlements [16,27]. Evidence that the toxic effect is a result of euplotins action 
comes from separate experiments carried out in vitro where a non-producing strain of E. vannus (TB6) 
was treated with varying concentrations of pure 7 and a 7-DIMEB complex at 10 µ g/mL. In both cases 
a 100% reduction on the viable protozoa was observed within one hour. These results confirm that the 
complexation process does not influence the activity of 7, while control experiments verified that the 
effect of dimethylsulfoxide (DMSO) or DIMEB was negligible. At the functional level, euplotin C 
kills non-producing Euplotes cells, whereas at sublethal levels it alters cell cycle, ciliary motility and 
cell shape [27]. These findings suggest that euplotin C may play an ecological role, representing an 
adjuvant factor of the multicomponent strategy pursued by E. crassus in broadening its niche size.  
These results, in conjunction with the fact that many natural products from marine resources show 
pharmaceutical and medical relevance, prompted the investigation into the potential in vitro bioactivity 
of  euplotin  C  (7)  against  the  non-marine  pathogenic  protozoa  Leishmania  major  and  Leishmania 
infantum, the opportunistic yeast Candida albicans and several prokaryotic microorganisms [40]. The 
toxicity of 7 against the macrophage-like cell line J774 was used as a mammalian host cell control. 
DMSO at a non-toxic concentration and DIMEB as a solubilizing agent in water for 7 were also used 
in the assays. Both free-7 and complexed-7 (i.e., DIMEB-7 1:1 inclusion complex) demonstrated good 
antileishmanicidal activity at 20 μg/mL, causing irreversible fatal damage. After 24 h, LD50 values of 
4.6 ±  0.5 and 8.1 ±  1.8 μg/mL for free-7 and complexed-7 respectively, were recorded. By contrast, the 
LD50 value was >200 μg/mL for the control J774 cell line. Subsequent studies on the activity of E. 
crassus (a euplotin-producer) and E. vannus (a non-producer) towards both L. major and L. infantum 
were in agreement with the data from the isolated compound, and found that cellular contact with E. 
crassus SSt22 strain causes irreversibly damage to parasitic cells, while the E. vannus TB6 strain does 
not induce any effect. Although the required amount of euplotin C is too high to be interesting for drug 
applications, the absence of any cytotoxicity towards the macrophage cells is quite promising. 
Further  bioactivity  results  revealed  that  at  high  concentrations  of  >100  μg/mL,  7  showed  an 
inhibitory effect on the yeast Candida albicans and on several strains of the bacteria Streptococcus and 
Burkholderia spp., whilst at lower concentrations only marginal antimicrobial activity was observed 
[40]. Interestingly, the complexed-7 form was noted to be more active in longer test times than free-7, 
possibly due to the higher chemical stability of the former. An inhibitory effect has also been observed Mar. Drugs 2010, 8                       
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for euplotin C on food vacuole formation and fluid phase endocytosis in Paramecium primaurelia, a 
process that might be mediated by an altered function of cell membranes as well as by modification of 
the microtubule network [42,43]. 
The underlying cellular and molecular basis of the effects of euplotin C were recently elucidated 
using mouse and rat tumor-derived cell lines, followed by the analysis of the nuclear and cytosolic 
changes usually associated with apoptosis in specific cell lines [29,45]. The apoptotic process is an 
auto-programmed mode of cell death that is dependent upon energy, as it requires ATP to transmit the 
death  signal  from  the  cytoplasm  to  the  nucleus.  It  also  causes  well-defined  morphological  and 
biochemical  changes  in  the  cell  such  as  cell  shrinkage,  chromatin  condensation,  nucleosomal 
degradation and changes in intracellular cation concentration such as Ca
2+. The cytotoxicity of 7 was 
tested  on  the  murine  AtT-20  line  derived  from  anterior  pituitary  tumor  cells  and  the  PC12  line 
originating from a rat chromaffin cell tumor, which expresses properties common to both neurons and 
neurosecretory cells. It was found that treatment of mouse and rat tumor cells with euplotin C resulted 
in a dose-dependent cytotoxic effect and in the induction of apoptotic cell death by cellular stress that 
triggered the activation of the caspase cascade. 
Finally, cellular responses to euplotin C in E. vannus have recently been investigated by analyzing 
the cytosolic changes likely to be associated with cytotoxicity and apoptosis, i.e., intracellular Ca
2+ 
concentration,  organelle  components  and  related  caspases  [46].  The  most  important  and  general 
outcome of this study is that the chemical signal carried by euplotin is transduced in a rapid impairing 
of the membrane electrical properties. This causes motility disorders which in turn hinders the ciliate’s 
ability to escape the external threat. After some minutes the fate of non producers is sealed because the 
ion channel pumps are completely impaired [43]. These results suggest that euplotin C exerts a marked 
disruption of homeostatic mechanisms, which play a determinant role in cell-environment interactions.  
4. Terpenoids from Euplotes raikovi  
4.1. Structures, chemical reactivity and synthesis  
While  euplotins  are  built  on  an  unsaturated  dioxa-tricyclic  system,  the  structural  feature  of  
E. raikovi metabolites is the bicyclo[3.2.0]heptane ring system [47]. However, different populations of 
E.  raikovi  produce  C(10)-epimeric metabolites,  providing  evidence for intra-species  variability. In 
particular, the strain Mor1 collected on the Casablanca coast contains raikovenal (14) and its putative 
biogenetic precursor preraikovenal (15), while all other strains so far examined [48] (GA8, SB8, 39W, 
LPSA5)  produce  the  C(10)  epimer  of  raikovenal  (epiraikovenal,  16)  and  its  seco-analog 
(secoepiraikovenal, 17) (Scheme 5).  
The chemical and spectroscopic properties of epimeric sesquiterpenoids 18 and 20 are, as expected, 
quite similar. Although this close structural similarity complicates the de-replication process, the two 
epimers can easily be distinguished by NMR spectroscopy since the 
13C resonance of Me-C(10) in 20 
is almost 6 ppm downfield with respect to the same carbon resonance in 18. The opposite trend is 
observed for the proton resonance of Me-C(10), which results in an upfield shift of 0.05 ppm in 20 
with respect to 18. This turns out to be very useful in the de-replication process, since this signal can 
easily be detected, even in 
1H-NMR spectra performed on crude cell extracts.  Mar. Drugs 2010, 8                       
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Scheme 5. Top: Sesquiterpenoids isolated from cell cultures of Euplotes raikovi. Bottom: 
MM  minimized  structures  of  raikovenal  18  [left,  ß -Me-C(10)]  and  epiraikovenal  20  
[right, -Me-C(10)].  
 
While  the  structure  elucidation  of  these  metabolites  was  in  progress,  interesting  investigations 
began into the photochemical conversions among xenicane diterpenes isolated from a brown alga of 
the genus Dictyota [49,50]. Motivated by the success of these studies, it was hypothesized that the 
bicyclo  ring  system  embedded  in  raikovenal  could  be  obtained  by  direct  photo-irradiation  of  its 
putative precursor, preraikovenal (19) (Scheme 6). Since [2 + 2]-cycloadditions are photochemically 
allowed processes, it was decided to sacrifice the small amount of the natural isolated compound 19, in 
an attempt to obtain an intramolecular photochemical cyclization leading to 18 and/or to 20. Irradiation 
at  350 nm of a chloroform solution of preraikovenal produced raikovenal as a minor product, while 
the  major  product  had  a 
1H-NMR  spectrum  that  was  superimposable  to  that  of  epiraikovenal  
(Scheme 6). According to the proposal [48], the photochemically produced raikovenal 18 could derive 
from a [2 + 2] concerted reaction (passing through the diradical intermediate 23) from the boat-like 
conformation of preraikovenal (19b). On the other hand, the photochemically produced epiraikovenal 
20 can be explained only by assuming 19 adopts a chair-like conformation (19a), and passes through 
intermediate  22.  However,  if  one  looks  at  Scheme  6,  the  expected  stereoisomer  from  the 
intramolecular addition of the reactive chair-like conformation is not 20, but its enantiomer ent-20. 
Indeed, it was demonstrated that the major product (epiraikovenal 20) obtained after purification of the 
photoaddition product mixture showed a circular dichroic (CD) spectrum opposite to that of natural 
epiraikovenal 20, thus indicating the compound to be ent-20. Although the absolute configuration at 
the chiral center at C(7) of natural 19 has not yet established, the outcome of this experiment clearly 
indicates  not  only  that  the  photoaddition  is  a  strongly  stereocontrolled  process  but  also  that  the 
inversion of chirality at C(7) is required in order to obtain natural epiraikovenal 20.  Mar. Drugs 2010, 8                       
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Scheme  6.  Photochemical  conversion  of  preraikovenal  (19)  into  raikovenal  (18)  and  
ent-epiraikovenal (ent-20). 
 
Two independent and different strategies for the total synthesis of racemic 18 and 20 have been 
reported. The first synthesis described exploits the photochemical methodology in the key step of the 
bicyclo[3.2.0]heptane ring construction [51]. In the same year (1997), Rosini et al. [52], relying on a 
completely different approach, reported another interesting total synthesis of racemic raikovenal. 
4.2. Biogenetic considerations 
Scheme 7. Biogenetic proposal for Euplotes raikovi sesquiterpenoids.  
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According to the results discussed above, if it is assumed that preraikovenal (19) is the putative 
biogenetic precursor of natural raikovenal (18), this would suggest that the enzymes involved in the 
bicyclic  ring  formation  preferentially  accommodate  and  recognize  substrate  19  in  a  boat-like 
conformation  (19b).  This  is  supported  by  MM  calculations,  which  show  this  conformation  to  be 
relatively stable due to the release of the repulsive 1,3-diaxial interaction of the methyl groups in the 
relevant transition state between preraikovenal and the intermediate 25 (Scheme 7). In order to explain 
the  production  of  20  and  21,  an  enantiomeric  chair-like  preraikovenal  form,  ent-19a,  would  be 
required. Since the photocyclization of preraikovenal (19) gave mainly ent-20, the conformer ent-19a 
is proposed herein to be the biogenetic precursor of epiraikovenal (20). 
4.3. Intra-morphospecies phylogenetic analysis 
Euplotes raikovi appears as a group with intra-morphospecific heterogeneity, characterized by the 
synthesis of one or two related terpenes. In particular, the strain Mor1 contains raikovenal and its 
putative biogenetic precursor preraikovenal, while all other strains so far examined produce the C(10) 
epimer of raikovenal (epiraikovenal) and its seco-analog (secoepiraikovenal). Considering that one 
metabolite  and  its  epimer  require  different  biogenetic  pathways,  it  was  hypothesized  that  the 
production  of  functional  alternatives  embedded  in  the  same  bicyclo[3.2.0]heptane  skeleton  is  an 
ecological strategy of adaptation that could also be seen by phylogenetic studies. The phylogenetic tree 
obtained  for  E.  raikovi  shows  the  evolutionary  split  between  the  strain  Mor1  and  the  fairly 
homogeneous  group  comprised  of  representatives  of  other  strains  with  cosmopolitan  distribution 
(Figure 5). This is in fair agreement with the natural product divergence discussed above. As with the 
euplotins for E. crassus, the production of raikovenal/epiraikovenal structures by all strains enables 
their use as taxonomic markers at the morphospecies level. 
Figure 5. Schematic representation of the phylogenetic tree, based on SSU-rRNA gene 
sequence comparisons, of different strains of Euplotes raikovi. The number at the node is 
the bootstrap percentage from 1000 replicates. The scale bars correspond to a distance of 5 
substitutions per 10000 nucleotide positions. 
 
4.4. Ecological role and biological activities 
The terpenoids from E. raikovi are less active than euplotins against other ciliates belonging to the 
genus  Euplotes.  Greater  activity  was  observed  [48]  against  Litonotus  strains,  ciliates  with  a 
E. raikovi  
(strain Mor1) 
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0.0005  
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characteristic predacious life-style which are killed by 18 at concentration as low as 10 g/mL, and by 
19–21 at higher concentrations. It is worth to note that euplotin C (7) was ineffective against the same 
predator suggesting the possibility of fine-tuned recognition phenomena in ciliated cells. Biological 
assays on raikovenal and related molecules demonstrated no killing activity against other ciliates even 
at concentrations above 20 g/mL. Two particular features were noted in these experiments. First, 
epiraikovenal was able to depress the fission rate in E. vannus and E. rariseta strains. However, this 
effect  does  not  seem  to  be  specific,  as  these  strains  are  sensitive  to  various  aldehyde-terpenoids. 
Second, it appears that certain E. raikovi strains use a combination of preraikovenal-raikovenal and 
epiraikovenal-secoepiraikovenal as a defensive strategy. These compounds appear to be effective only 
in synergy against predators such as Litonotus, accounting for the non-palatability of the strains [48]. 
5. Terpenoids from Euplotes vannus 
When attention was focused on the secondary metabolites of the morphospecies Euplotes vannus, 
another  member  of  the  marine  Euplotes  vannus-crassus-minuta  species  complex,  it  soon  became 
apparent that the greater biodiversity of the E. vannus morphospecies is mirrored by a greater diversity 
of secondary metabolites. The number of E. vannus strains analyzed so far is fewer than for E. crassus, 
reflecting  the  lower  probability  in  isolating  these  organisms  from  sand  samples.  However,  these 
analyses suggest that several E. vannus subgroups differ in terms of their metabolic productions. This 
scenario is likely to result from a divergence from a common ancestor and/or intra-morphospecies 
variability.  
5.1. Structures, chemical reactivity and synthesis  
As summarized in Scheme 8, from tropical strains (Sil21, BUN3) of E. vannus morphospecies, two 
unusual compounds with a novel C30 backbone, named vannusal A (26) and vannusal B (27) were 
isolated [53]. On the other hand, investigation of two different strains (TB6 and CM1) led to the 
isolation of new regular sesquiterpenoids such as hemivannusal (28) and prevannusadial A (29) and  
B (30) [54].  
Scheme 8. Terpenoids isolated from cell cultures of Euplotes vannus.  
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The structure elucidation of vannusals was extremely challenging [53]. Although the molecular 
formula suggested mono- and di-acetylated triterpenoid structures, it soon became evident that these 
were not regular triterpenes deriving from squalene or squalene-oxide internal cyclizations, and in fact 
cannot be considered triterpenoids at all. There is high structural complexity in the central part of these 
structures, wherein five- and six-membered rings are interlaced in fused, bridged and spiro forms. A 
further difficulty arose from the violation of the “isoprenic rule” in these metabolites in the central and 
more intricate part of the molecules. Natural products chemists’ penchant for this rule is well known 
since it poses strong constrains on the overall skeleton, thereby minimizing the number of candidate 
structures  compatible  with  the  spectral  data.  Much  assistance  in  the  structure  determination  was 
obtained by functional group transformation of 26 into a series of derivatives [53], which ultimately 
revealed the intricate nature of the vannusal A structure.  
The relative stereochemistry of several chiral centers in the vannusals has recently been revised 
(Scheme 8 and Figure 6) [54–61]. The stereoselective total synthesis of vannusal A and B (26 and 27) 
carried out by Nicolaou et al. confirms the overall structure and main stereochemical architecture of 
vannusals. In fact, if the relative stereochemistry at C(25) is not considered, the only difference in 
terms of the relative configurations between the proposed [53] and the revised structures [54,56,60,61] 
of  vannusals  derive  from  the  mis-assigned  relative  stereochemistry  at  C(6)–C(7).  This  led  to  the 
assignment of the wrong relative stereochemistry of the chiral centers in the “eastern” domain of the 
molecule with respect to those in “western” one. The brilliant syntheses designed and executed in 
recent  years  in  the  Nicolaou  laboratory  has  finally  solved  this  intricate  matter  through  the  total 
synthesis of eight diastereomeric vannusal B structures [60,61].  
Figure 6. Minimized structure of vannusal A (26). Only -H atoms on chiral centers are represented.  
 
Even the structural elucidation of hemivannusal 28 [54] was not a simple task. In particular, the 
assignment of the relative stereochemistry of its 3 chiral centers, which requires correlation between 
the stereochemistry of the chiral centers on the rings linked together via a carbon-carbon single bond 
(C6–C7), around which free rotation is expected to occur. Thus, both the relevant vicinal coupling 
(
3J6,7)  and  the  dipolar  mutual  effects  (NOE)  between  the  same  protons  H(6)  and  H(7)  represent 
averaged values among several C6–C7 rotamers. Assistance in resolving this problem was obtained 
through an extended conformational search performed within a molecular mechanics approach and 
refined by ab initio quantum chemical calculations. 
The minor metabolites of the CM1 strain, prevannusadial A (29) and prevannusadial B (30), were 
isolated in very low amounts. Their structures were established [54] by direct comparison of their  Mar. Drugs 2010, 8                       
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1H-NMR spectra with those reported in the literature for the “diterpenoid 9” [62] isolated by Paul and 
Fenical from a Caribbean Udotea species (U. flabellum) and for petiodial isolated by Fattorusso et al. 
[63] from the Mediterranean U. petiolata. Prevannusadial B represents the deprenyl analog of these 
Udotea diterpenoids. This situation has a strong resemblance with that already discussed of the linear 
sesquiterpenoid preuplotin (8), with udoteal isolated from the tropical green alga U. flabellum [28].  
5.2. Biogenetic considerations 
The possible biosynthetic origin of E. vannus metabolites is proposed in Scheme 9 along similar 
lines to that of the E. crassus terpenoids. The biosynthesis of hemivannusal 28 may derive from FPP 
and prevannusadial A (29) precursors through three enzymatic processes. After C1 pyrophosphate 
hydrolysis, C(14) and C(15) methyl group oxidation would afford the putative intermediate 15 (see 
also Scheme 4) bearing two ,-unsaturated aldehyde functions with Z stereochemistry. Following 
ZE isomerization of the C6,7 double bond, the intermediate 31 could then lead i) to 29, after ZE 
isomerization of the C2,3 double bond and ii) to the intermediate 32, after oxidation of the allylic 
hydroxyl  group  of  29  and  enolization  of  the  C(15)  aldehyde  group.  The  intermediate  32  can  be 
converted via intramolecular addition of the activated nucleophilic center C(2) to C(6), an electrophilic 
center due to its  position in the conjugated unsaturated system, leading to prevannusadial B (30). 
The latter could readily react through an intramolecular C(14)–C(10) carbonyl-ene process affording 
the  bicyclic  intermediate  33.  The  main  metabolite  of  the  strain  TB6,  hemivannusal  (28),  can  be 
obtained after i) acetylation of the free primary –OH group and ii) internal redox reaction taking place 
in the saturated cyclopentane ring, a process having precedent in literature reports on carbonyl-ene 
synthetic procedures [63].  
Scheme 9. Biogenetic proposal for Euplotes vannus sesquiterpenoids.  
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As already outlined in the proposed euplotin biosynthesis (Scheme 4), the unusual route involving 
methyl oxidation and nucleophilic additions seems to be a feature shared by strains belonging to the 
morphospecies E. vannus. Divergence among secondary metabolites of the two species occurs at the 
level of the putative  common intermediate  15. Furthermore, it relies  on the strong preference for 
acetalization processes in  E. crassus leading to the highly strained tricyclic skeleton of euplotins, 
compared  to  carbonyl-ene  reactions  in  E.  vannus  strains  leading  to  the  hemivannusane  skeleton. 
Further evidence of this is given by the C30 terpenoids vannusal A and B (26 and 27). Although first 
thought to arise from a deviation of the squalene pathway to triterpenes, they are now considered as 
end-products of the nucleophilic condensation of two molecules possessing the regular hemivannusane 
sesquiterpenoid skeleton (28), via the hypothetical aldol-derived intermediates 34 and 35 (Scheme 10). 
The C30 terpenoids are possibly derived from a concerted condensation of the “peripheral” C1 and 
C15 electron-poor carbonyl groups of the first hemivannusane intermediate with the “internal” C2' and 
C3'  electron-rich  centers  of  the  second  intermediate.  This  biosynthetic  proposal  was  exploited  by 
Nicolaou et al. in their recent stereoselective total synthesis of the vannusals 26 and 27 [60,61].  
Scheme 10. Biogenetic proposal for Euplotes vannus C30 terpenoids (vannusals).  
 
5.3. Intra-morphospecies phylogenetic analysis  
In the morphospecies E. vannus the chemodiversity of its secondary metabolites mirrors its genetic 
diversity, as revealed by the phylogenetic analysis. This significant intra-morphospecific variability in 
the secondary metabolite production is also reflected in the phylogenetic tree. E. vannus branches in at 
least two distinct genetic groups, with each group comprising representatives producing only one of 
the different classes of secondary metabolites isolated (Figure 7).  
Phylogenetic analysis suggests that all the strains examined to-date constitute a monophyletic clade. 
From a natural products viewpoint this is advantageous. It means that the evolution of E. vannus 
utilizes different secondary molecular characters, not only useful as chemical biomarkers to distinguish 
different populations of the same morphospecies, but also as important representative of new chemical 
structures that could be exploited as new bioactive molecules.  Mar. Drugs 2010, 8                       
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Figure 7. Schematic representation of the phylogenetic tree, based on SSU-rRNA gene 
sequence comparisons, of different strains of Euplotes vannus. The numbers at the nodes 
are bootstrap percentages from 1000 replicates. The scale bars correspond to a distance of 
2 substitutions per 100 nucleotide positions. 
 
6. Terpenoids from Euplotes rariseta  
6.1. Structures, chemical reactivity and synthesis 
Analysis of the sesquiterpenoids isolated from E. rariseta (Scheme 11) suggests a scenario similar 
to that already discussed for E. raikovi. For example, different strains of the same morphospecies 
collected in different geographical areas produce two epimeric sesquiterpenoids, rarisetenolide (36) 
(and its epoxide 37) and the corresponding C(10) epimer, epirarisetenolide (38) [65], built on a novel 
octahydroazulene ring system. So far, only the relative configurations of these terpenoids have been 
established.  
In a series of experiments aimed at elucidating the structures of these terpenoids, the expected 
mixture  of  hemiacetal  epimers  at  C(14)  was  obtained  in  good  yields  by DIBAL reduction  of the 
lactone group of 36. At the same time, it was also demonstrated that the -ß  conjugated lactone could 
be removed by nucleophilic addition at the unsaturated C(3)=C(4) double bond. Indeed, UV irradiation 
( 254 nm) of a methanol solution of rarisetenolide (36) in a quartz cuvette at room temperature gave 
good  yields  of  the  corresponding  4-methoxy  derivative.  Addition  of  MeOH  rather  than  loss  of 
conjugation under UV irradiation is in accordance with the proposed lactone structures.  
As for the C(10) epimeric raikovenals 18/20, the structural similarity between the C(10) epimeric 
metabolites 36/38 complicates the dereplication process. However, the problem is readily solved using 
NMR spectroscopy. The 
1H resonance of Me-C(10) (H 2.90, dt) in rarisetenolide is 0.5 ppm downfield 
with respect to the same proton resonance in epirarisetenolide (H 2.49, dt), and their vicinal coupling 
patterns are also different. These signals can easily be detected in 
1H-NMR spectra, even in crude cell 
extracts, and thus it is possible to distinguish which one of the two epimers, 36 or 38, a given strain 
produces. Until now, a strain of E. rariseta that produces both epimers has not yet been found. This is 
indicative of a selective and/or different enzymatic pool in populations of this ciliate or the use of 
enantiomeric biogenetic precursors. 
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Strains Sil21 and BUN3 
 Strain TB6 
 Strain CM1 
0.02  
E. vannus (group A) 
 E. vannus (group B) 
91 
6
9 
8
0 Mar. Drugs 2010, 8                       
 
 
2102 
Scheme  11.  Top:  Terpenoids  from  cell  cultures  of  Euplotes  rariseta.  Bottom:  MM 
minimized  structures  of  raristenolide  36  [left,  ß   H-C(10)]  and  epirarisetenolide  38  
[right,  H-C(10)]. 
 
6.2. Biogenetic considerations 
The proposed biosynthesis of rarisetenolide from FPP via the intermediate 44 is shown in Scheme 
12. After C1 pyrophosphate hydrolysis of FPP, oxidation of the C(14) and C(15) methyl groups would 
afford the putative intermediate 39 bearing a saturated aldehyde at what was the C(6)=C(7) double 
bond. Aldol condensation of this aldehyde with the activated nucleophilic center at C(2), followed by 
proton tautomerization leads to the intermediate 40. This could then react through an intramolecular 
C(14)–C(10) carbonyl-ene process affording the bicyclic intermediate  42, which upon dehydration 
produces 43. This intermediate is proposed to play a pivotal role undergoing acetalization/oxidation 
processes leading to rarisetenolide-like metabolites through intermediate  44. Herein, C(14) is thus 
considered  as  the  electrophilic  center  for  the  nucleophilic  attack  of  both  C(2)  and  C(10).  If  it  is 
considered that FPP methyl groups are rarely involved in intramolecular terpenoid cylizations, the 
enzymatic processes able to build the octahydroazulene ring system of 36 or 38 appears to be a unique 
feature of ciliate secondary metabolism. It should be noted however, that the putative linear precursor 
(i.e., “prerarisetenolide”) has not yet been isolated. The C(6)/(7) hydrogenated analog 39, the C(14) 
oxidized  form of preraikovenal  (19),  should  contain  all  the structural  and stereochemical features 
required to produce the octahydroazulene ring system of 36 and 38. Furthermore, it could also give 
rise to divergent routes towards 36 or 38, depending on the absolute configuration at its C(7) chiral 
center. Thus, it is proposed that evolutionary differentiation among E. rariseta strains could rely on 
C(7) enantiomeric FPP oxidized precursors, such as 39, in a similar way as differentiation among  
E. raikovi could rely on the enantiomeric FPP oxidized precursors 19 and ent-19.  Mar. Drugs 2010, 8                       
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Scheme 12. Biogenetic proposal of Euplotes rariseta metabolites. 
 
6.3. Intra-morphospecies phylogenetic analysis  
The strains of the morphospecies E. rariseta analyzed for the secondary metabolite production have 
been collected from various coastal sites, including those of northern and southern Australia (strains 
PD16 and PBH1, respectively), southern Brazil (strain BR1), Canary Islands (strain GRH5), and New 
Zealand (NZ2) [65]. All of them are found to be producers of non-aldehydic terpenoids, which is quite 
unusual  in  the  Euplotes  genus.  The  three  sesquiterpenoids  identified,  rarisetenolide, 
epoxyrarisetenolide, and epirarisetenolide, share the same octahydroazulene moiety, which seems to 
be a convincing chemotaxonomic marker of the morphospecies.  
Figure 8. Schematic representation of the phylogenetic tree, based on SSU-rRNA gene 
sequence comparisons, of different strains of Euplotes rariseta. The numbers at the nodes 
are bootstrap percentages from 1000 replicates. The scale bars correspond to a distance of 
5 substitutions per 10000 nucleotide positions.  
 
As with E. crassus and E. vannus, this morphospecies also shows intra-morphospecific variability 
in its secondary metabolite production that is reflected in the phylogenetic partition. The four strains of 
E. rariseta (PD16, PBH1, BR1 and GRH5) produce both rarisetenolide and epoxyrarisetenolide. These 
strains,  although  collected  from geographically distinct locations, are  all phylogenetically grouped 
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together in the same clade (Figure 8). It is difficult to believe that this is a coincidence. The production 
of  secondary  metabolites  is  related  to  enzymes  coded  by  the  organism’s  genome,  their  presence 
reflecting the expression of functional genes, and the inference of a close phylogenetic relationship 
among  the  above  strains  is  warranted.  In  contrast  to  the  other  strains,  the  strain  NZ2  gives 
epirarisetenolide,  revealing  a  subtle  variability  in  secondary  metabolism  for  this  ciliated 
morphospecies. The epimeric relationship of this metabolite with rarisetenolide implies the presence of 
different metabolic pathways in strain NZ2 with respect to the other strains. This is indicative of 
genetic differentiation of strain NZ2 as revealed by the phylogenetic tree (Figure 8).  
6.4. Biological activities 
Cytotoxicity of rarisetenolide (36) and its congeners (37 and 38) against representatives of the 
marine interstitial ciliate community, comprising E. rariseta itself, was detected only at relatively high 
doses, i.e., >20 g/mL. The only exception observed was towards the ciliate Litonotus lamella, which 
proved sensitive to 36 at lower doses. It is worth noting that L. lamella differs from all other ciliates 
involved in the bioassays due to its behavior as a predator. It can be proposed that the effectiveness of 
36 against L. lamella is part of a defensive strategy of E. rariseta to avoid predation. Since lower 
cytotoxicity of the chemically more reactive epoxide 37 with respect to 36 or 38 was found in the 
ecological  tests,  interactions  with  membrane  receptors  of  the  Euplotes  morphospecies  might  be  
non-covalent in nature. 
7. Terpenoids from Euplotes focardii 
7.1. Structures, chemical reactivity and synthesis 
Strains assigned to the species E. focardii have been found to produce the focardins (Scheme 13) 
[66], which show much of the structural characters of the rarisetenolide/epirarisetenolide family. From 
the morphospecies collected from Antarctica (strain TN1) and inter-tropical coastal waters (strains 
GBS1 and GBS5), a new skeletal class of diterpenoid, epoxyfocardin (46), was isolated. Focardin (42), 
which is a possible biogenetic precursor of 46, was also isolated as a minor component. Focardins 
constitute  the  first  example  of  ecologically  relevant  metabolites  from  ciliate  species  that  inhabit  
polar ecosystems. 
Scheme 13. Diterpenoids from cell cultures of Euplotes focardii.  
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Focardin (45) was isolated as a 70:30 mixture of hemiacetals  45a and 45b. These equilibrated 
through  the  unstable  ring-opened,  aldehyde  intermediate  47  (Scheme  14),  to  ultimately  give 
epoxyfocardin (46) as an 85:15 mixture of its corresponding hemiacetals 46a and 46b. Evidence of the 
equilibrium of the diasteroisomeric hemiacetals came from the analysis
 1H-NMR spectra of pure 46a 
obtained by reversed-phase chromatography of raw extract containing 46 which was superimposable to 
that  obtained  before  the  separation.  An  unaltered  ratio  of  products  clearly  suggests  equilibrium 
conditions among the epimers. The absolute configuration of 46a/46b was determined from Mosher's 
method [30] through esterification of the hemiacetal hydroxyl group.  
Scheme 14. Hemi-acetal equilibration among C(20) epimers of focardin (45). 
 
7.2. Biogenetic considerations 
The  proposed  biosynthesis  of  the  E.  focardii  metabolites  described  here  commences  from 
geranylgeraniol pyrophosphate (GGPP) and involves (in the first steps) similar intermediates to those 
involved in rarisetenolide biosynthesis, albeit with one prenyl unit more (Schemes 12 and 15). Herein, 
C(19) is playing the same role as C(14) in the raristenolide pathway, but a striking difference between 
rarisetenolide and focardin biosynthesis is represented by the different oxidation states of C(1) and 
C(15)/C(20). Whereas in the formation of 36 (or 38), C(1) is in a lower oxidation state than C(15), in 
45 (or 46) it is in a higher oxidation state than C(20).  
Scheme 15. Biogenetic proposal for Euplotes focardii metabolites. 
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7.3. Intra-morphospecies phylogenetic analysis  
By  morphological  and  morphometrical  analysis,  all  Antarctic  and  inter-tropical  populations  of  
E. focardii constituted a single cluster of indistinguishable units, thus allowing their attribution to the 
same morphotype. Nevertheless, within the morphospecies two distinct groups, which corresponded to 
the  two  geographical  areas  of  sampling  (Antarctic  and  inter-tropical  regions),  were  detected  by 
phylogenetic  analysis  (Figure  9).  Interestingly,  this  genetic  polymorphism  is  also  reflected  by 
secondary metabolite production. In fact 45 and 46 can be isolated in higher yields from the inter-
tropical strains GBS1 and GBS5, whereas the Antarctic TN1 strain produces them only in low amounts 
(Figure 9). This observation suggests that competition for exploitable niches and food varies with 
latitudes, thus the survivor strategies are also expected to vary. In particular in the inter-tropical area 
the metabolite expression would be expected to be higher, since E. focardii inter-tropical populations 
must cope with higher species competition than the Antarctic strains of the same morphospecies. 
Figure 9. Schematic representation of the phylogenetic tree, based on SSU-rRNA gene 
sequence comparisons, of different strains of Euplotes focardii. The numbers at the nodes 
are bootstrap percentages from 1000 replicates. The scale bars correspond to a distance of 
1 substitution per 1000 nucleotide positions. 
 
7.4. Biological activities 
The paucity of suitable test organisms prevented the investigation of the ecological role of focardin 
and epoxyfocardin, but the high bioactivity of the latter against predacious ciliates such as L. lamella 
and L. cygnus suggests a defensive role for these substances. This would indicate that ciliates are in 
strong  competition  even  in  Antarctica.  Of  the  two  diterpenoids,  focardin  (45)  showed  the  least 
cytotoxic activity. E. focardii showed a significant cytotoxic activity vs. various ciliate morphospecies, 
including congeneric species of the ciliate Litonotus, a notorious predator of Euplotes specimens. Due to 
difficulties  in  accomplishing  long  lasting  experiments  using  psychrophilic  ciliate  strains  (growing  at 
temperatures close to water-freezing), after 24 h of Litonotus predaction activity, the disappearance of 
Euplotes representatives of different morphospecies in the sample community was significantly larger than 
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that  observed  when  the  sample  ciliate  community  included  specimens  of  E.  focardi.  Toxic  activity 
counteracting  predation  by  Litonotus  may  be  guessed  for  the  substances  produced  by  E.  focardii. 
Focardin’s low bioactivity and low abundance in E. focardii infers a minor role for this metabolite  
in nature. 
8. Functional Role and Phylogenetic Significance  
The modern construction of phylogenetic trees and evolutionary events concerning species is based 
on molecules that are found in all organisms, such as ribosomal RNA (rRNA) and highly conserved 
proteins, or polymorphic enzymes for population structure and dynamics. Some species, however, 
compete for space and resources, or defend themselves from predators, largely due to their secondary 
metabolites, which are potentially their best taxonomic and phylogenetic markers [67].  
It  is  well  known  that  terpenes  act  as  defensive  substances  for  a  variety  of  marine  organisms 
including algae, sponges, corals, mollusks and fish [71]. For example, caulerpenyne is an acetylenic 
sequiterpene found in certain species of green algae, which is rapidly converted into highly reactive 
1,4 dialdehydes by esterase enzymes that are activated upon wounding [69]. Chemical defense is also 
typical in the poorly defended, shell-less opisthobranch mollusks, which accumulate terpenes both 
from their diet and from de novo biosynthesis [70]. 
As  described  recently  [71],  biosynthetic  pathways  leading  to  secondary  metabolites  may  have 
evolved to favor molecular diversity, although the explanation on how the evolution has followed its 
course is a matter of debate. From the point of view of the “target-based” model of natural product 
evolution  [72,74],  certain  secondary  metabolites  could  confer  a  survival  benefit  to  an  organism 
through  their  ability  to  specifically  bind  to  cellular  targets  in  competing  organisms.  This  belief, 
however,  relies  on  the  assumption  that  natural  product/receptor  interactions  are  comparable  to 
enzyme/substrate interactions [72]. From the point of view of the “diversity-based” model (originally 
named the “screening” model [73,75]), evolution would favor organisms that “could generate and 
retain  chemical  diversity  at  low  cost”.  Here  the  assumption  is  that  organisms  producing  a  wider 
chemical  diversity  should  have  greater  chances  of  producing  metabolites  with  potent  biological 
activity [75]. Herein, almost two decades of comparative analysis of the secondary metabolism and 
phylogenesis  of  marine  ciliates  of  the  family  Euplotidae  from  temperate  and  tropical  marine 
environments  is  described.  The  synergistic  contribution  of  expertise  coming  from  biological 
(microbiology,  molecular  biology  and  ecology)  and  chemical  (analytical  and  synthetic  organic 
chemistry) disciplines has created the opportunity to propose a global picture of the ciliate protistan 
world to-date.  
Marine interstitial ciliates belonging to the genus Euplotes have emerged as a rich source of new 
terpenoids  bearing  various  functionalities.  Furthermore,  these  terpenoids  display  activities  against 
other ciliates, competing for space and resources,
 and also possess interesting biological properties 
such as apoptotic activity towards mouse and rat tumor cell lines [29,45]. Generally, the lipophilic 
nature  of  these  compounds  indicates  that  their  principal  targets  are  likely  to  be  cell  membranes, 
wherein  they  could  play  a  role  in  chemioosmotic  control  [46].  Moreover,  there  is  evidence  from 
bioassays that terpenoids are non-covalently bound to the ciliate’s external membrane.  Mar. Drugs 2010, 8                       
 
 
2108 
From an evolutionary point of view, the structural chemo-diversity among ciliate metabolites is not 
unexpected because it reflects the biological imperative to maximize biodiversity starting with both a 
minimal  substrate  pool  and  minimal  genetic  alterations  [76].  It  also  provides  evidence  that  the 
biodiversity and adaptive ability of marine ciliates is higher than what was previously thought. From a 
structural point of view, many of the ciliate secondary metabolites isolated so far are regular, often 
polycyclic terpenoids, which are proposed to originate from the biogenetic precursors FPP or GGP 
through  the  involvement  of  species-specific  enzymes.  In  particular,  four  different  sesquiterpenoid 
skeletons  have  been  isolated  and  demonstrated to  be  species-specific:  i.e.,  euplotane  (E. crassus), 
raikovane (E raikovi), rarisetane (E. rariseta) and hemivannusane (E. vannus) (Scheme 16). The latter 
is thought to be the biogenetic precursor of the unusual C30 vannusane metabolites. The putative 
linear precursors to three of the above (preuplotin, preraikovenal and prevannusadial A), deriving from 
methyl oxidations of FPP along with C(6)=C(7) double bond isomerizations, have been isolated from 
strains of the corresponding morphospecies (E. crassus, E. raikovi and E. vannus, respectively). On the 
other hand, the proposed linear precursor of rarisetenolide (“preraristenolide”) has never been found in 
any strain of E. rariseta. The unifying picture of the secondary metabolites in marine ciliates depicted 
in Scheme 16 assumes that epimeric products 18/20 observed in E. raikovi, and 36/38 in E. rariseta, 
should  derive  from  enantiomeric  forms  of  the  corresponding  linear  precursors.  It  has  also  been 
demonstrated  that  another  diterpenoid  structure,  focardane,  is  a  chemotaxonomic  marker  of  the 
morphospecies E. focardii.  
Scheme 16. Metabolic routes towards terpenoids produced by marine ciliates of the genus Euplotes. 
 
To  gain  insight  into  the  phylogenetic  relationships  among  Euplotes  species,  SSU-rRNA  gene 
sequences of representatives belonging to the different marine species were determined and aligned in 
order to compare molecular phylogenesis with secondary metabolite production. The results obtained 
clearly define not only the relationships among the different populations of the same morphospecies Mar. Drugs 2010, 8                       
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(intraspecific phylogenetic trees) as already discussed in previous sections (see Figures 4, 5, 7–10), but 
also the relationships among different Euplotes morphospecies (interspecific phylogenetic tree). The 
latter  indicates  the  monophyly  of  the  taxon  Euplotes,  characterized  by  the  following  particular 
features: (1) E. raikovi branches basal to the other species; (2) E. crassus, E. vannus, and E. minuta 
form a stable group positioned at the apex of the phylogenetic tree; (3) E. focardii is the sister species 
of the previous group; (4) E. rariseta occupies an intermediate position and is more phylogenetically 
related  to  the  clade  E.  crassus  -  E.  vannus  -  E.  minuta  -  E.  focardii  than  to  E.  raikovi  species  
(Figure 10). 
The production of secondary metabolites at the morphospecies level is consistent with the results 
described above. Three different compounds, the euplotins A–C and their precursor preuplotin, have 
been  isolated  from  E.  crassus.  The  other  two  members  of the  E. vannus-crassus-minuta complex 
produce only small amounts of preuplotin (E. minuta) or are characterized by the complete absence of 
euplotins (E. vannus). This latter species is instead characterized by the production of a variety of 
compounds,  with  different  populations  of  E.  vannus  giving  regular  sesquiterpenes  such  as 
hemivannusal, prevannusadial A, and prevannusadial B, while others give dimeric sesquiterpenes such 
as  vannusal  A  and  vannusal  B,  and  others  appear  not  to  produce  any  terpenoid  secondary 
metabolites.These results suggest (Scheme 16 and Figure 10) that E. crassus is a species that has 
developed  a  homogeneous  set of secondary molecular characters,  and  evolution of this  species  is 
destined either to maintain all these characters (euplotins A–C) or to lose all of them. In contrast, the 
evolution of E. vannus utilizes different sets of secondary molecular characters to distinguish different 
populations. 
Figure 10. Schematic representation of the phylogenetic tree, based on SSU-rRNA gene 
sequence comparisons, of different species of Euplotes and their main terpenoid secondary 
metabolites isolated to-date. The numbers at the nodes are the bootstrap percentage from 
1000  replicates.  The  scale  bars  correspond  to  a  distance  of  2  substitutions  per  100 
nucleotide positions. 
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From an evolutionary perspective, it could be said that genes implied in the secondary metabolism 
of the TB6 strain (E. vannus) have evolved from divergence of ancestral homologous genes of the 
CM1 strain, since the latter are (and were) not able to encode enzymes for the biosynthesis (Figures 5 
and 6) of the bicyclic terpenoid hemivannusal from prevannusadial A. On the other hand, strains Sil21 
and BUN3 should have the most diverse genes since they are able to carry out the reaction even further 
than hemivannusal, affording “dimeric” C30 terpenoids such as vannusal A. Of course, it also possible 
that  it  is  not  new  genes,  which  have  arisen  by  gene  duplication  followed  by  divergence,  but  an 
increased expression of genes encoding new enzymes and, hence, new chemical processes which are 
not expressed in the ancestors.  
Some  morphospecies  appear  to  be  much  more  homogeneous  than  others  (e.g.,  E.  raikovi), 
suggesting different evolutionary strategies. This result must be interpreted according to the recent 
reported evidence [39], which shows that within ciliate morphospecies, there is sufficient isolation to 
allow separation of genomes without morphological differentiation. Moreover, the high number of 
strains  genetically  analyzed  for  each  morphospecies  indicates  the  existence  of  an  internal  genetic 
variability that undermines the general assumption that morphospecies equate to an evolutionary unit. 
Interestingly, these genetic intra-morphospecific groups have their exact counterpart in the outcome of 
the  chemotaxonomic  approach.  This  analysis  shows  that  different  strains  belonging  to  the  same 
morphospecies  but  grouped  in  different  genetic  clades,  are  characterized,  both  qualitatively  and 
quantitatively, by a different profile of secondary metabolites. 
9. Conclusions 
Unicellular ciliated protists represent an important component of the grazing marine food web, thus 
playing  a  key,  although  scarcely  investigated,  role  in  the  marine  ecosystem.  From  the  structural 
chemist’s point of view the most fascinating aspect of this trip into the world of ciliates is represented 
by the high skeletal chemical diversity found in this phylum. Using sesquiterpenoids as an example, 
the isolation of four new C15 skeleta was unexpected at the beginning of the study, since more than a 
century of research had been dedicated not only to the identification of new metabolites but also to 
explain the mechanism of their biosynthesis. Although experimental biogenetic investigations on the 
origin of ciliate secondary metabolites have not yet been carried out, it is quite clear from the isolated 
metabolites that marine ciliates have a unique enzymatic system able to deviate from the usual course 
of  the  linear  terpenoid  precursors.  Typically,  sesquiterpene  synthases  (cyclases)  catalyze  the 
cyclization of FPP into any one of the 300 known hydrocarbon skeletons. This involves ionization of 
the FPP pyrophosphate leaving group, followed by the generation of a reactive allylic carbocation and 
subsequent C-C bond formation (along with alkyl shifts), leading to a terminal carbocation that is 
finally quenched by a base [77]. The analysis of the sesquiterpenoid skeleta elucidated from marine 
ciliates so far strongly suggests that the methyl groups of FPP are oxidized in the early steps of the 
biosynthetic  route  affording  the  novel  linear  precursors.  Thereafter,  the  corresponding  aldehyde 
carbonyl groups are extensively used as electrophilic centers in subsequent reactions.  Thus, in the 
biosynthetic proposals herein, the oxidations which occur in the early steps may predispose the linear 
precursors to follow a particular path towards the novel end-products observed. The challenges for the 
future will be to substantiate this view with experimental findings, to isolate and characterize the Mar. Drugs 2010, 8                       
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terpene  cyclases  involved  and  to  exploit  the  great  advancements  of  molecular  biologists  towards 
mapping of the marine ciliate genome. The powerful tools of molecular biology coupled with recent 
advances in analytical chemistry will enable future investigation into terpene production from marine 
ciliates “manipulated” by genetic knockouts or by the use of low-molecular-weight elicitors.  
Finally, it is often reported that secondary metabolite production could be mediated by prokaryotic 
(bacteria) endosymbionts harboured by eukaryotic microorganisms. Actually, ciliate cells represent a 
suitable  niche  for  endosymbiotic  colonizers,  mainly  of  prokaryotic  nature.  Furthermore,  specific 
bacterial endosymbionts characterize several Euplotes taxa and are known to infect all the members of 
the comprised populations. Treatment with antibiotic drugs (e.g., penicillin) has demonstrated that 
specific features of the eukaryotic guests are bestowed on the prokaryotic hosts. Euplotes vannus intra-
population  variability  allowed  us  to  isolate  both  the  significantly  infected  strain  TB6  and  the 
endosymbiont-free strain Male5 [54]. According to the phylogenetic analysis based on 18S rRNA, 
ITS1, ITS2 (nuclear), and 16S rRNA (mitochondrial) gene sequences, Male5 has been demonstrated to 
be genetically identical to the TB6 strain. The HPLC-MS analysis of an organic extract obtained from 
a small-scale cell culture of this strain (E. vannus, Male5) clearly indicated the presence of the same 
major secondary metabolite (hemivannusal (22)) in almost the same amount as that produced by the E. 
vannus  TB6  infected  strain.  This  result  strongly  suggests  that  22,  but  reasonably  also  all  the 
metabolites  so  far isolated  from marine ciliates  belonging  to  the genus  Euplotes, are  “true ciliate 
metabolites” rather than products of the harbored prokaryotic endosymbionts. 
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